BSE Live
Nov 14, 16:01Prev. Close
826.05
Open Price
831.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 14, 15:59Prev. Close
826.15
Open Price
827.90
Bid Price (Qty.)
812.65 (14)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Natco Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 26.08 | 36.22 | 39.38 | 28.27 | 10.17 | |
| Diluted EPS (Rs.) | 26.01 | 36.10 | 39.24 | 28.24 | 10.14 | |
| Cash EPS (Rs.) | 31.46 | 40.94 | 41.39 | 31.43 | 13.03 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 212.61 | 195.24 | 169.40 | 97.40 | 76.80 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 212.61 | 195.24 | 169.40 | 97.40 | 76.80 | |
| Dividend / Share(Rs.) | 6.75 | 6.25 | 8.25 | 6.75 | 1.25 | |
| Revenue from Operations/Share (Rs.) | 98.36 | 108.84 | 113.35 | 112.21 | 58.70 | |
| PBDIT/Share (Rs.) | 38.56 | 51.85 | 52.46 | 40.41 | 16.87 | |
| PBIT/Share (Rs.) | 33.17 | 47.46 | 48.91 | 37.34 | 13.99 | |
| PBT/Share (Rs.) | 32.04 | 46.43 | 48.11 | 36.34 | 12.73 | |
| Net Profit/Share (Rs.) | 26.07 | 36.55 | 37.84 | 28.36 | 10.14 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 39.20 | 47.64 | 46.27 | 36.01 | 28.74 | |
| PBIT Margin (%) | 33.72 | 43.60 | 43.14 | 33.27 | 23.83 | |
| PBT Margin (%) | 32.57 | 42.66 | 42.44 | 32.38 | 21.68 | |
| Net Profit Margin (%) | 26.50 | 33.58 | 33.38 | 25.27 | 17.28 | |
| Return on Networth / Equity (%) | 12.26 | 18.72 | 22.33 | 29.11 | 13.20 | |
| Return on Capital Employed (%) | 15.14 | 23.75 | 28.44 | 37.50 | 17.84 | |
| Return on Assets (%) | 10.21 | 15.31 | 18.68 | 21.08 | 9.57 | |
| Total Debt/Equity (X) | 0.08 | 0.11 | 0.06 | 0.13 | 0.07 | |
| Asset Turnover Ratio (%) | 38.52 | 45.59 | 55.97 | 83.42 | 55.42 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 3.40 | 3.19 | 3.64 | 1.70 | 1.65 | |
| Quick Ratio (X) | 2.60 | 2.48 | 2.89 | 1.15 | 0.92 | |
| Inventory Turnover Ratio (X) | 3.41 | 3.91 | 4.91 | 5.81 | 2.90 | |
| Dividend Payout Ratio (NP) (%) | 26.84 | 13.77 | 21.61 | 23.76 | 12.35 | |
| Dividend Payout Ratio (CP) (%) | 22.24 | 12.29 | 19.75 | 21.44 | 9.61 | |
| Earnings Retention Ratio (%) | 73.16 | 86.23 | 78.39 | 76.24 | 87.65 | |
| Cash Earnings Retention Ratio (%) | 77.76 | 87.71 | 80.25 | 78.56 | 90.39 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 9,471.83 | 10,553.50 | 13,916.81 | 14,975.65 | 7,225.47 | |
| EV/Net Operating Revenue (X) | 5.29 | 5.31 | 6.65 | 7.65 | 7.07 | |
| EV/EBITDA (X) | 13.50 | 11.15 | 14.38 | 21.24 | 24.61 | |
| MarketCap/Net Operating Revenue (X) | 5.15 | 5.25 | 6.65 | 7.55 | 7.02 | |
| Retention Ratios (%) | 73.15 | 86.22 | 78.38 | 76.23 | 87.64 | |
| Price/BV (X) | 2.38 | 2.93 | 4.45 | 8.70 | 5.37 | |
| Price/Net Operating Revenue | 5.15 | 5.25 | 6.65 | 7.55 | 7.02 | |
| Earnings Yield | 0.05 | 0.06 | 0.05 | 0.03 | 0.02 |
14.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
14.10.2025
Natco Pharma shares fall 3.5% as SC agrees to urgently list Roche's plea on Risdiplam launch
10.10.2025
Natco Pharma shares jump 6% after Delhi HC allows firm to sell 'Risdiplam' in India
10.10.2025
14.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
09.09.2025
Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y
05.06.2025
Natco Pharma Standalone March 2025 Net Sales at Rs 1,157.40 crore, up 19.96% Y-o-Y
03.06.2025
Natco Pharma Consolidated March 2025 Net Sales at Rs 1,221.00 crore, up 14.29% Y-o-Y